Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Corvus Pharmaceuticals (CRVS) Receivables - Other (2022 - 2024)

Corvus Pharmaceuticals (CRVS) has 3 years of Receivables - Other data on record, last reported at $70000.0 in Q3 2024.

  • For Q3 2024, Receivables - Other changed N/A year-over-year to $70000.0; the TTM value through Sep 2024 reached $70000.0, changed N/A, while the annual FY2023 figure was $26000.0, 95.58% down from the prior year.
  • Receivables - Other reached $70000.0 in Q3 2024 per CRVS's latest filing, up from $35000.0 in the prior quarter.
  • Across five years, Receivables - Other topped out at $588000.0 in Q4 2022 and bottomed at $26000.0 in Q4 2023.
  • Average Receivables - Other over 3 years is $269222.2, with a median of $373000.0 recorded in 2022.
  • The widest YoY moves for Receivables - Other: up 15.01% in 2023, down 95.58% in 2023.
  • A 3-year view of Receivables - Other shows it stood at $588000.0 in 2022, then tumbled by 95.58% to $26000.0 in 2023, then surged by 169.23% to $70000.0 in 2024.
  • Per Business Quant database, its latest 3 readings for Receivables - Other were $70000.0 in Q3 2024, $35000.0 in Q2 2024, and $26000.0 in Q1 2024.